What should I do if I develop resistance to entecavir?

Dec 02, 2025 Source: Cainiu Health
Dr. Gao Jun
Introduction
Entecavir is an antiviral drug commonly used to treat chronic hepatitis B. After the development of entecavir resistance, it is essential to promptly perform drug resistance genotyping, adjust the antiviral regimen, consider combination therapy to enhance efficacy, strictly adhere to medical instructions for medication, and regularly monitor disease progression to prevent viral rebound and worsening liver damage. If resistance-related symptoms such as fatigue or jaundice occur, prompt medical attention is recommended.

Entecavir is a commonly used antiviral drug for the treatment of chronic hepatitis B. After the development of entecavir resistance, it is essential to promptly perform drug resistance gene testing, adjust the antiviral regimen, use combination therapy to enhance efficacy, strictly follow medical instructions, and regularly monitor disease progression to prevent viral rebound and worsening liver damage. If symptoms related to drug resistance such as fatigue or jaundice occur, prompt medical attention is recommended.

1. Perform drug resistance gene testing: Identify specific resistance mutations through testing to determine whether the resistance is primary or secondary, providing accurate guidance for subsequent treatment adjustments and avoiding blind medication changes.

2. Adjust the antiviral regimen: Based on test results, switch to or add drugs without cross-resistance under medical supervision, such as tenofovir disoproxil fumarate or tenofovir alafenamide, to ensure continuous effectiveness of antiviral therapy.

3. Use combination therapy to enhance efficacy: For patients with multiple drug resistance or high viral load, combination treatment using two drugs with different mechanisms of action can reduce the risk of further resistance and rapidly suppress viral replication.

4. Strictly adhere to medical instructions: Avoid self-discontinuation, dose reduction, or switching of medications. Take prescribed medications on time and in the correct dosage to prevent improper use from inducing further resistance and compromising treatment outcomes.

5. Regularly monitor disease progression: After developing resistance, increase the frequency of follow-up tests to monitor viral load, liver function, and liver fibrosis markers, allowing timely assessment of treatment response and dynamic adjustment of therapeutic strategies.

Maintain a regular lifestyle and avoid staying up late. Quit smoking and alcohol to reduce liver burden. Eat a light, easily digestible diet rich in high-quality protein and vitamins. Avoid physical overexertion and emotional fluctuations, and rigorously implement the treatment plan to support stable disease control.

Related Articles

View All